Abstract
Adverse childhood experiences (ACEs) are linked to increased risk of a host of health outcomes in adulthood. Descriptive ACEs prevalence studies have previously identified that Multiracial people have the highest mean ACE score of any racial group, but do not offer explanations for these disparities. However, Multiracial people form one of the fastest-growing populations in the US, and the largest subgroup of Multiracial people is those that claim American Indian/Native American (AI/NA) ancestry. Mean ACE counts (scores) are also high among the AI/NA population, which may reflect impacts of land occupation and structural racism. This descriptive study uses data from the National Longitudinal Study of Adolescent to Adult Health (Add Health) to test the hypothesis that mean ACE scores and prevalence of ACE components are higher among Multiracial AI/NA participants than Multiracial non-AI/NA participants. Mean scores were highest among AI/NA (mean = 3.21, 95% CI: 2.54, 3.97), Multiracial AI/NA (2.95, 95% CI: 2.71, 3.18), Multiracial non-AI/NA (2.88, 95% CI: 2.57, 3.19), and Black (2.84, 95% CI: 2.65, 3.02) groups. Differences in mean ACE scores and prevalence of ACE components between the two Multiracial groups were all insignificant. Results from this study did not support our hypothesis, suggesting that the Multiracial population’s high ACE scores are not driven primarily by those with AI/NA ancestry. Future studies should repeat this analysis in larger datasets and explore other determinants of high mean ACE scores among the Multiracial population.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work was supported by NIH-NCATS-CTSA grant UL1TR003142 and contract 75D30122P12974 with the Centers for Disease Control and Prevention.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Office for Protection of Human Subjects of the University of California, Berkeley waived ethical approval for this work.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
This analysis used restricted data (made available through a data use agreement); a public-use subset is available online.
